Chester County News and Community Website
PHILADELPHIA, PA — GSK (LSE: GSK; NYSE: GSK) and Spero Therapeutics (Nasdaq: SPRO) said the U.S. Food and Drug Administration has approved Utebzi, the first oral carbapenem antibiotic for adults …
FDA Clears GSK Antibiotic for Drug-Resistant UTI Patients Read More PHILADELPHIA, PA — GSK plc (LSE/NYSE: GSK) launched a new phase of its Ask2BSure meningitis awareness campaign featuring actors Julie Bowen and Ty Burrell as the drugmaker intensifies outreach aimed …
GSK Expands Meningitis Campaign With Julie Bowen, Ty Burrell Read More PHILADELPHIA, PA — GSK plc (NYSE: GSK) said the U.S. Food and Drug Administration has expanded approval of its RSV vaccine AREXVY to include adults ages 18 to 49 who …
FDA Expands GSK RSV Vaccine Use to At-Risk Adults Ages 18–49 Read More PHILADELPHIA, PA — GSK plc (LSE/NYSE: GSK) announced new real-world effectiveness data for its RSV vaccine, AREXVY, showing an association with reduced RSV-related hospitalizations in adults 60 and older.
GSK Reports RSV Vaccine Data on Hospitalization Risk Read More PHILADELPHIA, PA — GSK plc (LSE/NYSE: GSK) has awarded $2 million to 16 nonprofit organizations nationwide as part of its COiMMUNITY Initiative, intensifying efforts to improve immunization education, access, and …
GSK Backs Vaccine Push With $2M Grants as U.S. Immunization Gaps Loom Read More PHILADELPHIA, PA — GSK plc (LSE/NYSE: GSK) has awarded nearly $1 million in grant funding to nonprofit organizations across the United States aimed at improving diagnosis, treatment, and long-term care …
GSK Awards Nearly $1M to Fuel Community Fight Against Lupus Nationwide Read More PHILADELPHIA, PA — As vaccination gaps persist across the United States, GSK announced it has awarded $2 million in grants to 16 nonprofit organizations nationwide, backing community-driven efforts to boost …
GSK Unleashes $2M Grant Push to Battle Vaccine Gaps, Pledges More for 2026 Read More PHILADELPHIA, PA — GSK plc (LSE/NYSE: GSK) said the U.S. Food and Drug Administration has approved Exdensur, a twice-yearly biologic treatment for patients with severe asthma characterized by an eosinophilic …
FDA Clears GSK’s Twice-Yearly Asthma Drug, Signaling Shift in Biologic Care Read More PHILADELPHIA, PA — GSK plc (LSE/NYSE: GSK) announced that the U.S. Food and Drug Administration has approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone (BVd) for adult patients …
GSK Wins FDA Approval for Blenrep Combo in Advanced Multiple Myeloma Read More PHILADELPHIA, PA — GSK plc (LSE/NYSE: GSK) has unveiled a major update to its Vaccine Track platform, expanding the interactive public data tool to include vaccination trends across 387 U.S. …
GSK Expands Vaccine Track With Metro-Level Data to Advance Adult Immunization Insights Read More